Description

What if clogged arteries did NOT cause heart attacks?Did you know . . . .When we look carefully at the angiograms (where we squirt dye into the arteries in the heart to see if they are blocked) of people who are having or who have recently had an MI, in some we find the artery is blocked and in others we don’t. I have been studying this seeming paradox for a long time.The story of how I came to understand the cause, and therefore the appropriate treatment, of acute coronary syndrome involves fascinating elements of surprise and serendipity. I thought it best, therefore, to describe how this tale unfolded for me.In a 1998 editorial in The American Journal of Cardiology, Dr. W.W. O’Neill commented about a paradox in recent findings. In a number of trials of myocardial infarctions (MIs, or heart attacks), many of the patients who suffered recent MIs were not found to have blockages in the arteries that led to the area of the heart that had suffered the infarction.SPEAKER:  Thomas Cowan, MD, discovered the work of the two men who would have the most influence on his career while teaching gardening as a Peace Corps volunteer in Swaziland, South Africa. He read Nutrition and Physical Degeneration by Weston Price and a fellow volunteer explained the arcane principles of Rudolf Steiner’s biodynamic agriculture. These events inspired him to pursue a medical degree. Dr. Cowan has served as vice president of the Physicians Association for Anthroposophical Medicine and is a founding board member of the Weston A. Price Foundation. He is a regular contributor to our “Ask the Doctor” column and the Foundation’s quarterly journal. Dr. Cowan is the author of The Fourfold Path to Healing, a companion book to Nourishing Traditions by Sally Fallon.A single MP3 audio file — 1 hour, 10 minutesPlus bonus footage from Wise Traditions ConferenceA lecture at the Wise Traditions Conference 2010 of the Weston A. Price Foundation — famous of outstanding nutrition education from sources that are untainted by profit seeking corporations or special interest groups supported by pharmaceutical companies or government agencies.